amonganalysisburdencardiovascularcarecombinationcomparisondapagliflozindipeptidyldppeffectivenesseffectsempagliflozinglpglucoseindiainhibitorinhibitorskidneylinagliptinmellitusmetametforminoutcomespatientspeptidasereviewsafetysglt2studysystematictherapytreatmenttypeyoung